Interestingly these authors have also indicated that Thy-1/CD90-β3 integrin interaction inhibits ovarian cancer formation (Chen et al., 2016) and in this case, CD133 decreases its expression in cancer stem cells, while the phosphorylation of AMPK increases. The gene discussed is THY1; the disease is ovarian carcinoma.